GlaxoSmithKline to pay $3B in health care fraud suit
WASHINGTON (KABC) -- British drug maker GlaxoSmithKline will pay an unprecedented $3 billion in fines and has agreed to plead guilty to criminal charges.
The Justice Department announced the health care fraud settlement Monday morning, making it the largest payment ever by a drug company.
The pharmaceutical giant is accused of illegally promoting the anti-depressants Paxil and Wellbutrin. Prosecutors say GlaxoSmithKline promoted uses for those drugs that were not approved.
The company is also accused of failing to report heart risks associated with its diabetes drug Avandia.
Accompanying the criminal case was a civil settlement in which the government said the company's improper marketing included providing doctors with expensive resort vacations, European hunting trips, high-paid speaking tours and even tickets to a Madonna concert.
The Associated Press contributed to this report.
fraud, legal, business
- Santa Ana jewelry store robbery caught on cam
- Nelson Mandela mourners pay last respects
- Pope Francis named Time's Person of the Year
- Auto thefts up in CA after realignment -study
- Man arrested in 'revenge porn' website case
- FBI arrest several alleged MS-13 gang members
- UC Riverside employee diagnosed w/ meningitis
- LA supervisors criticize Baca amid jail probe
- Bell moving forward after Spaccia conviction
- Budget deal: Liberals, conservatives grumbling 35 min ago
- abcnews: Woman claws way out of locked bathroom
- Paul Walker crash: 2nd theft suspect surrenders 18 min ago
- US Navy sailor surprises family on ABC comedy
- OTRC: Demi Lovato's cocaine, alcohol confessions
- Latest weather with Garth Kemp
41 min ago